Compositions and methods for altering XLHED phenotypes

• 收藏
• 分享

专利权人:

エディマー ファーマシューティカルズ インコーポレイテッド

发明人:

シュナイダー、パスカル,コヴァルチック、クリスティン

申请号：

JP2014510458

公开号：

JP5955382B2

申请日:

2012.05.10

申请国别(地区):

JP

年份:

2016

代理人:

摘要：

The invention relates to methods for the temporal administration of EDA agonists, in particular EDI200, which correlate to optimal therapeutic response windows required for the formation of any EDA-dependent structures such as ectodermal appendages. Use of the methods described allow for the design of targeted therapeutic dosing and administration regimens in order to correct or alter abnormal phenotypes associated with genetic disorders, in particular, XLHED.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/